Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis

被引:134
作者
Dahl, KE
Shiratsuchi, H
Hamilton, BD
Ellner, JJ
Toossi, Z
机构
[1] CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,CLEVELAND,OH 44106
[2] UNIV CLEVELAND HOSP,CLEVELAND,OH 44106
[3] VET ADM MED CTR,CLEVELAND,OH 44106
关键词
D O I
10.1128/IAI.64.2.399-405.1996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The induction of macrophage-deactivating (interleukin-10 [IL-10] and transforming growth factor beta [TGF-beta]) and macrophage-activating (IL-1, IL-6, and tumor necrosis factor alpha [TNF-alpha]) cytokines by lipoarabinomannan (LAM) from pathogenic Mycobacterium tuberculosis Erdman and H37Rv strains (ManLAM) and nonpathogenic mycobacteria (AraLAM) in human blood monocytes was examined. ManLAM was significantly less potent in induction of TNF-alpha, IL-1, IL-6, and IL-10 protein and mRNA, whereas its ability to induce TGF-beta was similar to that of AraLAM. Differences in induction of TNF-alpha mRNA by the two LAM preparations only became apparent at late time points of culture (24 h). The induction of TNF-alpha and IL-1 by purified protein derivative of M. tuberculosis was significantly stronger than that by ManLAM. Pretreatment of monocytes with ManLAM did not, however, interfere with cytokine induction by lipopolysaccharide or AraLAM. The extensive mannosyl capping of arabinose termini of ManLAM may underlie the lack of ability to induce some cytokines (IL-1, TNF-alpha, and IL-10) and the retained ability to induce TGF-beta. The latter may have a role in shifting the cytokine milieu in favor of survival of M. tuberculosis.
引用
收藏
页码:399 / 405
页数:7
相关论文
共 36 条
  • [1] ARNOLDI J, 1990, AM J PATHOL, V137, P749
  • [2] EXPRESSION AND SECRETION OF TYPE-BETA TRANSFORMING GROWTH-FACTOR BY ACTIVATED HUMAN MACROPHAGES
    ASSOIAN, RK
    FLEURDELYS, BE
    STEVENSON, HC
    MILLER, PJ
    MADTES, DK
    RAINES, EW
    ROSS, R
    SPORN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) : 6020 - 6024
  • [3] AVERILL LE, 1993, REGULATION TUMOR NEC
  • [4] BARNES PF, 1990, J IMMUNOL, V145, P149
  • [5] TUMOR-NECROSIS-FACTOR PRODUCTION IN PATIENTS WITH LEPROSY
    BARNES, PF
    CHATTERJEE, D
    BRENNAN, PJ
    REA, TH
    MODLIN, RL
    [J]. INFECTION AND IMMUNITY, 1992, 60 (04) : 1441 - 1446
  • [6] BARNES PF, 1992, J IMMUNOL, V149, P541
  • [7] BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006
  • [8] BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P9
  • [9] BURCHETT SK, 1988, J IMMUNOL, V140, P3473
  • [10] LIPOARABINOMANNAN, A POSSIBLE VIRULENCE FACTOR INVOLVED IN PERSISTENCE OF MYCOBACTERIUM-TUBERCULOSIS WITHIN MACROPHAGES
    CHAN, J
    FAN, X
    HUNTER, SW
    BRENNAN, PJ
    BLOOM, BR
    [J]. INFECTION AND IMMUNITY, 1991, 59 (05) : 1755 - 1761